The hosts question why HIV preventative drugs like Truvada are not available for free or over-the-counter if the goal is to "flatten the curve" of new infections. They highlight the high cost of these medications—up to $2,000 a month without insurance—and suggest the marketing is aimed at maintaining fear rather than solving the epidemic.

